MAUDE MDR 5216980

MDR report key
5216980
Report number
1226348-2015-10658
Event key
0
Event type
3
Date of event
2015-08-01
Date received
2015-11-11
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MR JAMES KENNEY
Address
325 PARAMOUNT DRIVE RAYNHAM MA 02767 US
Phone
508-508-5088
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1SURGICAL PATTIE, 1/2 X 1/2SURGICAL SPONGECODMAN & SHURTLEFF, INC.HBN80-1400UNKR N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12015-11-1101. R

Event Narratives#

N

Patient 1

IT HAS BEEN COMMUNICATED THAT THE DEVICE AND/OR LOT INFORMATION IS NOT AVAILABLE FOR EVALUATION. WITHOUT THE DEVICE AND/OR LOT INFORMATION IT IS NOT POSSIBLE FOR CODMAN TO CONDUCT A PROPER INVESTIGATION. IF AT SOME POINT THE DEVICE AND/OR LOT INFORMATION DOES BECOME AVAILABLE, THIS COMPLAINT WILL BE RE-OPENED, EVALUATED AND A FOLLOW UP REPORT WILL BE FILED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CONSIDERED CLOSED.

D

Patient 1

IN THE LITERATURE ARTICLE ?RADIOGRAPHIC DETECTABILITY OF RETAINED NEUROPATHIES IN A CADAVER MODEL? (2015) 84, 2:405-411, HTTP://DX.DOI.ORG/10.1016/J.WNEU.2015.03.032, IT WAS REPORTED THAT CODMAN NEURO PATTIES IN SIZES ? X ? AND ? X ? HAD IN ADEQUATE RADIOPACITY. COUNTS ARE THE COMMONEST METHOD USED TO ENSURE THAT ALL SPONGES AND NEUROPATHIES ARE REMOVED FROM A SURGICAL SITE BEFORE CLOSURE. WHEN THE COUNT IS NOT RECONCILED, PLAIN RADIOGRAPHS OF THE OPERATIVE SITE ARE TAKEN TO DETERMINE WHETHER THE MISSING PATTY HAS BEEN LEFT IN THE WOUND. THE PURPOSE OF THIS STUDY WAS TO DESCRIBE THE DETECTABILITY OF COMMONLY USED NEUROPATHIES IN THE CLINICAL SETTING USING DIGITAL TECHNOLOGIES. THREE SURGICAL SITES WERE CHOSEN: THE ANTERIOR CRANIAL FOSSA, THE POSTERIOR CRANIAL FOSSA, AND THE THORACOLUMBAR EXTRADURAL SPACE. EACH OPERATIVE SITE WAS DRAPED IN THE USUAL MANNER WITH DRAPES BEING SECURED WITH SURGICAL STAPLES TO SIMULATE TYPICAL INTRAOPERATIVE ARTIFACTS. CRANIOTOMIES AND LAMINECTOMIES WERE PERFORMED TO ALLOW ACCESS FOR THE PLACEMENT OF THE NEUROPATHIES. NEUROPATHIES (THE FOUR PRODUCTS TESTED IN OUR STUDY WERE, CODMAN (RAYNHAM, MA) SURGICAL PATTIES: 80-1399 1/4 _ 1/4 IN [64 _ 64 CM]; 80-1400 1/2 _ 1/2 IN [1.27 _ 1.27 CM]; 80-1406 1/2 _ 2 IN [1.27 _ 5.06 CM]; 80-1408 1 _ 3 IN [2.54 _ 7.62 CM]) WERE IMPLANTED IN RANDOMIZED COMBINATIONS INTO EACH SURGICAL SITE AND POSITIONED IN CLINICALLY RELEVANT SUBREGIONS AS DESCRIBED. UNDER SIMULATED OPERATING ROOM CONDITIONS AND USING CURRENTLY AVAILABLE NEUROPATHIES AND PLAIN RADIOGRAPH IMAGING TECHNOLOGY, SMALL 1/4-IN AND 1/2-IN NEUROPATHIES ARE POORLY VISIBLE/DETECTABLE ON DIGITAL IMAGES. AT THE TIME OF COMPLAINT ENTRY THERE ARE NO KNOWN LOT NUMBERS AND THE DEVICES ARE NOT AVAILABLE FOR ANALYSIS.